Evidence map›Paper›PMID 37999273›Full record

ReviewNanomaterials (Basel, Switzerland)2023

Iron Oxide Nanoparticles: Green Synthesis and Their Antimicrobial Activity.

Johana Zúñiga-Miranda, Julio Guerra, Alexander Mueller, Arianna Mayorga-Ramos, Saskya E Carrera-Pacheco, Carlos Barba-Ostria, Jorge Heredia-Moya, Linda P Guamán

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Hematite (α-FeChemistry & biodiversity · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Green synthesis of Ginkgo biloba-mediated magnetite (FeBioprocess and biosystems engineering · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Eco-friendly synthesis of FeFrontiers in microbiology · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Johana Zúñiga-MirandaCentro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.ORCID 0000-0001-9037-9306
Julio GuerraFacultad de Ingeniería en Ciencias Aplicadas, Universidad Técnica del Norte, Ibarra 100107, Ecuador.ORCID 0000-0001-5278-719X
Alexander MuellerDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.ORCID 0000-0002-7447-1310
Arianna Mayorga-RamosCentro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.
Saskya E Carrera-PachecoCentro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.ORCID 0000-0003-2351-5595
Carlos Barba-OstriaEscuela de Medicina, Colegio de Ciencias de la Salud Quito, Universidad San Francisco de Quito USFQ, Quito 170901, Ecuador.
Jorge Heredia-MoyaCentro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.ORCID 0000-0001-7620-9140
Linda P GuamánCentro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.ORCID 0000-0002-3756-2387
Universidad UTE · ECPrinceton University · USUniversidad San Francisco de Quito · ECUniversidad Técnica del Norte · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of antimicrobial resistance caused by inappropriate use of these agents in various settings has become a global health threat. Nanotechnology offers the potential for the synthesis of nanoparticles (NPs) with antimicrobial activity, such as iron oxide nanoparticles (IONPs). The use of IONPs is a promising way to overcome antimicrobial resistance or pathogenicity because of their ability to interact with several biological molecules and to inhibit microbial growth. In this review, we outline the pivotal findings over the past decade concerning methods for the green synthesis of IONPs using bacteria, fungi, plants, and organic waste. Subsequently, we delve into the primary challenges encountered in green synthesis utilizing diverse organisms and organic materials. Furthermore, we compile the most common methods employed for the characterization of these IONPs. To conclude, we highlight the applications of these IONPs as promising antibacterial, antifungal, antiparasitic, and antiviral agents.

Indexed as

antibacterial activityantifungal activityantimicrobial resistanceantiparasiticantiviral activitygreen synthesisIONPs

Identifiers

PMID37999273
PMCPMC10674528
OpenAlexW4388515872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.